NanoVibronix, Inc.

NasdaqCM:NAOV

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

🔬 Clinical Trials

🩺 Medical Instruments

💊 Pharmaceuticals

Location

United States

Market Cap

USD 2.38 M

Share Price

USD 0.92

Avg Daily Volume

4,255,698

Change (1 day)

-3.61%

Change (1 year)

Change (YTD)

-73.94%

NanoVibronix, Inc. Share Price Year-To-Date (YTD) return on June 20, 2025: -73.94%

NanoVibronix, Inc. Share Price Year-To-Date (YTD) return is -73.94% on June 20, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

NanoVibronix, Inc. 52-week low Share Price is USD 7.75 on June 20, 2025, which is 742.39% above the current Share Price.
NanoVibronix, Inc. 52-week low Share Price is USD 0.81 on June 20, 2025, which is -11.58% below the current Share Price.
NanoVibronix, Inc. average Share Price for the last 52 weeks is USD 3.33.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

NasdaqCM: NAOV

NanoVibronix, Inc.

CEO	Mr. Brian M. Murphy
IPO Date	May 28, 2015
Location	United States
Headquarters	525 Executive Boulevard
Employees	31
Sector	🏥 Health Care
Industries Biotechnology 🔬 Chemicals & Advanced Materials 🔬 Clinical Trials 🩺 Medical Instruments 💊 Pharmaceuticals

Description

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.